{"id":1186855,"date":"2026-09-04T23:30:28","date_gmt":"2026-09-04T23:30:28","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/1186855\/"},"modified":"2026-09-04T23:30:28","modified_gmt":"2026-09-04T23:30:28","slug":"could-vitamin-d-and-dha-be-a-winning-team-for-cognitive-decline","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/1186855\/","title":{"rendered":"Could vitamin D and DHA be a winning team for cognitive decline?"},"content":{"rendered":"

Published in Nutrients, the 12-month study by researchers at Tianjin Medical University in China found that co-supplementation suppressed blood biomarkers of neuroinflammation and delivered superior improvements in cognitive scores. <\/p>\n

\u201cThese findings highlight the potential of this combined supplementation as a safe, accessible, and mechanism-driven nutritional strategy for early intervention in cognitive decline,\u201d the researchers wrote. <\/p>\n

Dual neuroprotective mechanisms<\/p>\n

The trial builds on existing literature surrounding the independent brain health benefits of both vitamin D and omega-3 fatty acids.<\/p>\n

Vitamin D3 binds to its receptors in the brain to inhibit neuroinflammation and reduce amyloid beta accumulation. However, optimal blood levels for slowing the progression of age-related cognitive decline remain undefined in current clinical guidelines. <\/p>\n

In previous studies, omega-3 fatty acids, particularly DHA, have been associated with lowering the risk of cognitive decline and dementia by up to 20%<\/a>. As the most abundant omega-3 fatty acid in the brain, DHA is essential for maintaining neuronal membrane fluidity, supporting nervous system communication, and stimulating neuroprotective factors such as brain-derived neurotrophic factor (BDNF). <\/p>\n

Previous evidence suggests DHA may modulate vitamin D receptor activation, indicating that their mechanisms may be complementary and that their combination could be superior to single nutrients in preventing cognitive decline. <\/p>\n

The category\u2019s potential for combining the two nutrients is substantial, driven by an aging global population and consumer interest in preventive health products. <\/p>\n

Study details<\/p>\n

The study involved 355 participants aged over 65 with MCI who were randomly assigned to four groups that took a daily supplement for 12 months: VD3 (800 IU\/day), DHA (1 g\/day), VD3+DHA (VD3 800 IU\/day + DHA 1 g\/day), and placebo.<\/p>\n

At 6- and 12-month time points, the researchers assessed cognitive function using appropriate scales. <\/p>\n

Additionally, to explore underlying mechanisms, they measured a panel of five key blood biomarkers associated with NLRP3-mediated neuroinflammation, an inflammatory process in the brain present in neurodegenerative disorders. <\/p>\n

The researchers observed that at 12 months, all the intervention groups showed significant improvements in cognitive function and reductions in the five blood markers compared to the placebo group. <\/p>\n

When compared to the single interventions, the combined VD3 and DHA showed \u201csuperior cognitive improvements\u201d in cognitive scores and several subtests and reduced markers for <\/p>\n

pyroptosis, an inflammation-driven type of programmed cell death. The combined supplement also significantly reduced other inflammatory markers in the blood panel compared to the single supplements. <\/p>\n

The researchers called for further large-scale, randomized, double-blind, placebo-controlled trials with extended follow-up to validate these findings.<\/p>\n

Source: Nutrients, https:\/\/doi.org\/10.3390\/nu18172777<\/a>, \u201cEffects of a Combined Vitamin D3 and Docosahexaenoic Acid Intervention on Cognitive Function and Blood Pyroptotic Biomarkers in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized, Double-Blind, Placebo-Controlled Trial.\u201d Authors: J. Yuan et al. <\/p>\n","protected":false},"excerpt":{"rendered":"Published in Nutrients, the 12-month study by researchers at Tianjin Medical University in China found that co-supplementation suppressed…\n","protected":false},"author":2,"featured_media":1186856,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[4318],"tags":[157469,108797,115613,372,34933,105,4434,52301,16,15],"class_list":["post-1186855","post","type-post","status-publish","format-standard","has-post-thumbnail","category-nutrition","tag-banner","tag-capsule","tag-colorful","tag-diet","tag-female","tag-health","tag-nutrition","tag-sweet","tag-uk","tag-united-kingdom"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/1186855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=1186855"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/1186855\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/1186856"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=1186855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=1186855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=1186855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}